Co-Authors
This is a "connection" page, showing publications co-authored by Ignacio Martin-Loeches and Antoni Torres.
Connection Strength
5.222
-
Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? Eur Respir Rev. 2021 Mar 31; 30(159).
Score: 0.928
-
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe. Curr Opin Crit Care. 2018 10; 24(5):347-352.
Score: 0.788
-
Murepavadin: a new antibiotic class in the pipeline. Expert Rev Anti Infect Ther. 2018 04; 16(4):259-268.
Score: 0.756
-
Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century. Breathe (Sheff). 2017 Sep; 13(3):209-215.
Score: 0.731
-
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia. ERJ Open Res. 2019 Feb; 5(1).
Score: 0.204
-
The European Network for ICU-Related Respiratory Infections (ENIRRIs) ERS Clinical Research Collaboration. Eur Respir J. 2019 01; 53(1).
Score: 0.201
-
Appraisal of systemic inflammation and diagnostic markers in a porcine model of VAP: secondary analysis from a study on novel preventive strategies. Intensive Care Med Exp. 2018 Oct 20; 6(1):42.
Score: 0.198
-
Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia. PLoS One. 2018; 13(7):e0200504.
Score: 0.194
-
23rd International Symposium on Infections in the Critically Ill Patient. Med Sci (Basel). 2018 Feb 08; 6(1).
Score: 0.188
-
Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project. ERJ Open Res. 2017 Oct; 3(4).
Score: 0.186
-
Predictors of treatment failure and clinical stability in patients with community acquired pneumonia. Ann Transl Med. 2017 Nov; 5(22):443.
Score: 0.185
-
The research agenda in VAP/HAP: next steps. Intensive Care Med. 2017 09; 43(9):1389-1391.
Score: 0.176
-
Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021 Aug 09; 25(1):284.
Score: 0.060
-
Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021 05 25; 25(1):177.
Score: 0.059
-
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021 06; 9(6):622-642.
Score: 0.059
-
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge. EBioMedicine. 2021 Apr; 66:103291.
Score: 0.059
-
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021 02; 47(2):188-198.
Score: 0.058
-
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials. Clin Infect Dis. 2019 11 13; 69(11):1912-1918.
Score: 0.053
-
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr; 62(4):310-319.
Score: 0.050
-
Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study. J Crit Care. 2017 10; 41:91-97.
Score: 0.045
-
The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia. Thorax. 2017 09; 72(9):803-810.
Score: 0.044